State Street’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

State Street’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,882,180	Closed	-$290M	–	3733
2014 Q4	$290M	Buy	2,882,180 +767,770	+36%	+$59.7M	0.03%	498
2014 Q3	$140M	Buy	2,114,410 +41,169	+2%	+$2.7M	0.02%	706
2014 Q2	$145M	Buy	2,073,241 +30,029	+1%	+$2.04M	0.02%	714
2014 Q1	$149M	Buy	2,043,212 +5,011	+0.2%	+$374K	0.02%	691
2013 Q4	$140M	Buy	2,038,201 +13,125	+0.6%	+$850K	0.02%	701
2013 Q3	$129M	Buy	2,025,076 +646,033	+47%	+$39M	0.02%	712
2013 Q2	$66.6M	Buy	+1,379,043	New	+$67.8M	0.01%	935

State Street's CBST Position: Q1 2015 in Review

State Street sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 2,882,180 shares — an estimated $290M sold.

State Street first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $290M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

State Street reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
State Street sold 2,882,180 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $290M.
State Street first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
State Street's CUBIST PHARMACEUTICALS INC position peaked at $290M in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on State Street's 13F filing for Q1 2015, filed 15 May 2015.